Clinodiside A, an active metabolite in Clinopodii herba, alleviates dextran-sulfate-sodium-induced ulcerative colitis

Le résumé fourni par la source

Introduction Clinodiside A is a natural bioactive component of Clinopodii herba, a genuine regional herb from Anhui Province (China) with multiple biological activities. This study aimed to explore the therapeutic potential of Clinodiside A in ulcerative colitis (UC). Methods Dextran sulfate sodium (DSS) was used to establish UC models both in vivo and in vitro . The models were treated with Clinodiside A. Parameters including body weight, disease activity index (DAI) score, colon length, and inflammation were assessed. Iron overload, lipid peroxidation, and intestinal epithelial repair were also evaluated. In vitro experiments using HCT116 cells examined cell damage, motility, and recovery. Results Clinodiside A alleviated DSS-induced UC consequences, including weight loss, increased DAI score, colon shortening, and inflammation. These effects were associated with reduced iron overload, reduced lipid peroxidation, and enhanced intestinal epithelial repair. In HCT116 cells, Clinodiside A ameliorated damage, enhanced motility, and promoted recovery of the intestinal epithelium. Discussion Our research validates the therapeutic and protective effects of Clinodiside A from Clinopodii herba on UC and expands its application potential.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.